Integrated analyses of multiple ocular melanoma datasets revealed that DLL3 was a dysregulated methylation-driven gene in UM metastasis and could serve as a biomarker to predict the prognosis of patients with UM. This evidence concerns the gene DLL3 and ocular melanoma.